A Phase1 Clinical Trial to Evaluate the Safety, Mucosal and Innate Immunity of Adenovirus Type 26 HIV-1 Vaccine in Healthy, HIV-1 Uninfected Adults

被引:0
|
作者
Baden, L. R. [1 ]
Liu, J. [2 ]
Li, H. [2 ]
Walsh, S. [1 ]
Johnson, J. [1 ]
Milner, D. [1 ]
Seaman, M. [2 ]
Krause, K. [1 ]
Swan, E. [3 ]
Tucker, R. [1 ]
Weijtens, M.
Pau, M.
Dolin, R. [2 ]
Barouch, D. H. [2 ]
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] NIAID, DAIDS, NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:A124 / A124
页数:1
相关论文
共 50 条
  • [21] Use of Human Mucosal Tissue to Study HIV-1 Pathogenesis and Evaluate HIV-1 Prevention Modalities
    Dezzutti, Charlene S.
    Hladik, Florian
    CURRENT HIV/AIDS REPORTS, 2013, 10 (01) : 12 - 20
  • [22] Use of Human Mucosal Tissue to Study HIV-1 Pathogenesis and Evaluate HIV-1 Prevention Modalities
    Charlene S. Dezzutti
    Florian Hladik
    Current HIV/AIDS Reports, 2013, 10 : 12 - 20
  • [23] An HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected Adults
    Hay, Christine M.
    Wilson, Gregory J.
    Elizaga, Marnie
    Li, Sue
    Kochar, Nidhi
    Allen, Mary
    Sobieszczyk, Magdalena
    Frank, Ian
    Frahm, Nicole
    Tomaras, Georgia D.
    Egan, Michael
    Pensiero, Michael
    Eldridge, John
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A17 - A17
  • [24] Engaging innate immunity in HIV-1 cure strategies
    Nathan L. Board
    Milica Moskovljevic
    Fengting Wu
    Robert F. Siliciano
    Janet D. Siliciano
    Nature Reviews Immunology, 2022, 22 : 499 - 512
  • [25] TRIM5 and innate immunity to HIV-1
    Luban, J.
    Pertel, T.
    Neagu, M.
    Hausmann, S.
    Zufferey, M.
    De Castillia, C. S.
    FEBS JOURNAL, 2009, 276 : 57 - 57
  • [26] Engaging innate immunity in HIV-1 cure strategies
    Board, Nathan L.
    Moskovljevic, Milica
    Wu, Fengting
    Siliciano, Robert F.
    Siliciano, Janet D.
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (08) : 499 - 512
  • [27] Safety and Immunogenicity of a Multiclade HIV-1 DNA Vaccine Boosted by a Multiclade HIV-1 Ad5 Vaccine in HIV-Uninfected Adult Subjects (HVTN 204)
    Churchyard, G. J.
    Morgan, C.
    Keefer, M.
    Adams, E.
    Hural, J.
    Graham, B.
    Moodie, Z.
    Gray, G.
    Vardas, E.
    Bekker, L.
    McElrath, M. J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 18 - 18
  • [28] A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
    Churchyard, Gavin J.
    Morgan, Cecilia
    Adams, Elizabeth
    Hural, John
    Graham, Barney S.
    Moodie, Zoe
    Grove, Doug
    Gray, Glenda
    Bekker, Linda-Gail
    McElrath, M. Juliana
    Tomaras, Georgia D.
    Goepfert, Paul
    Kalams, Spyros
    Baden, Lindsey R.
    Lally, Michelle
    Dolin, Raphael
    Blattner, William
    Kalichman, Artur
    Figueroa, J. Peter
    Pape, Jean
    Schechter, Mauro
    Defawe, Olivier
    De Rosa, Stephen C.
    Montefiori, David C.
    Nabel, Gary J.
    Corey, Lawrence
    Keefer, Michael C.
    PLOS ONE, 2011, 6 (08):
  • [29] Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection
    Eron, JJ
    Ashby, MA
    Giordano, MF
    Chernow, M
    Reiter, WM
    Deeks, SG
    Lavelle, JP
    Conant, MA
    Yangco, BG
    Pate, PG
    Torres, RA
    Mitsuyasu, RT
    Twaddell, T
    LANCET, 1996, 348 (9041): : 1547 - 1551
  • [30] Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial
    Campbell, Mary S.
    Mullins, James I.
    Hughes, James P.
    Celum, Connie
    Wong, Kim G.
    Raugi, Dana N.
    Sorensen, Stefanie
    Stoddard, Julia N.
    Zhao, Hong
    Deng, Wenjie
    Kahle, Erin
    Panteleeff, Dana
    Baeten, Jared M.
    McCutchan, Francine E.
    Albert, Jan
    Leitner, Thomas
    Wald, Anna
    Corey, Lawrence
    Lingappa, Jairam R.
    PLOS ONE, 2011, 6 (03):